These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18474790)

  • 1. Gastrointestinal adverse effects of prostaglandin analogues.
    Papachristou GC; Ritch R; Liebmann JM
    Arch Ophthalmol; 2008 May; 126(5):732-3. PubMed ID: 18474790
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Efficacy and tolerability of prostaglandin analogs.
    Eisenberg D
    J Glaucoma; 2009 Aug; 18(6):498; author reply 498-9. PubMed ID: 19593206
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost.
    Herndon LW; Asrani SG; Williams GH; Challa P; Lee PP
    Arch Ophthalmol; 2002 Jun; 120(6):847-9. PubMed ID: 12049597
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
    Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
    Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).
    Birt CM; Buys YM; Ahmed II; Trope GE;
    J Glaucoma; 2010 Sep; 19(7):460-7. PubMed ID: 20051890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurring iris pigment epithelial cyst induced by topical prostaglandin F2 alpha analogues.
    Krohn J; Hove VK
    Arch Ophthalmol; 2008 Jun; 126(6):867-8. PubMed ID: 18541857
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical prostaglandin F(2alpha) analog induced poliosis.
    Chen CS; Wells J; Craig JE
    Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension.
    Pachimkul P; Yuttitham K; Thoophom P
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S81-7. PubMed ID: 21717884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
    Kobayashi H; Kobayashi K
    J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
    Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
    Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.
    Rossi GC; Pasinetti GM; Bracchino M; Bucarelli M; Franchin S; Cerqueti P; Bellini R; Caravati C; Celesia L; Clemente A; Tinelli C
    Expert Opin Pharmacother; 2009 Aug; 10(11):1705-11. PubMed ID: 19601697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.
    Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
    J Glaucoma; 2010 Mar; 19(3):199-206. PubMed ID: 19661825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern alchemy: fixed combinations of glaucoma drugs.
    Katz LJ
    Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
    [No Abstract]   [Full Text] [Related]  

  • 20. Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
    Brandt JD; Cantor LB; Katz LJ; Batoosingh AL; Chou C; Bossowska I;
    J Glaucoma; 2008; 17(3):211-6. PubMed ID: 18414107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.